However, there are some limitations in our study: firstly, the role of PSMA3-AS1/miR-29a-3p/STAT3 axis in PRAD needs to be further confirmed by further analyses of signaling pathways or transcriptomics. Here, STAT3 is linked to prostate adenocarcinoma.